![Simon Dumesnil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 20 568 $ in data 31/08/2026
Simon Dumesnil is an Independent Director at Pasithea Therapeutics Corp.
since 2021.
Mr. Dumesnil is also Director & Managing Partner at Dunraven Capital Partners Ltd. Former positions include Managing Director at UBS AG from 2010 to 2013; Director at Lehman Brothers International, Inc. from 2003 to 2008; Director at Lehman Brothers Special Financing, Inc. from 2008 to 2009; Director at Lehman Brother Holding, Inc. from 2008 to 2009; MD & Head-Structured Financing Group Americas at UBS Securities LLC from 2013 to 2018; and Chief Investment Officer at Bluestone Capital Management Ltd. from 2009 to 2010.
Education includes undergraduate studies at École des Hautes Études Commerciales de Paris and graduate studies at Bayes Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 24/07/2026 | 35.833 ( 0,11% ) | 20 568 $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| PASITHEA THERAPEUTICS CORP. | Direttore/Membro del Consiglio | 01/04/2021 |
Dunraven Capital Partners Ltd.
 Dunraven Capital Partners Ltd. MiscellaneousMiscellaneous Functions as an investment holding and financing company | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
UBS Securities LLC
 UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | 01/01/2018 |
UBS AG /Jersey Branch/
 UBS AG /Jersey Branch/ Major BanksFinance Provides wealth management, investment, retail and commercial banking services | Corporate Officer/Principal | 01/01/2013 |
Bluestone Capital Management Ltd.
 Bluestone Capital Management Ltd. Financial ConglomeratesFinance Provides financial intermediation services | Direttore degli Investimenti | 01/01/2010 |
Lehman Brother Holding, Inc. | Direttore/Membro del Consiglio | 01/01/2009 |
Lehman Bros. Special Financing, Inc.
 Lehman Bros. Special Financing, Inc. Investment Banks/BrokersFinance Provides securities brokerage services | Direttore/Membro del Consiglio | 01/01/2009 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
UBS Securities LLC
UBS Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
UBS AG /Jersey Branch/
UBS AG /Jersey Branch/ Major BanksFinance Provides wealth management, investment, retail and commercial banking services | Finance |
École des Hautes Études Commerciales de Paris
 École des Hautes Études Commerciales de Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayes Business School
 Bayes Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lehman Bros. Special Financing, Inc.
Lehman Bros. Special Financing, Inc. Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Bluestone Capital Management Ltd.
Bluestone Capital Management Ltd. Financial ConglomeratesFinance Provides financial intermediation services | Finance |
Lehman Brothers International, Inc.
 Lehman Brothers International, Inc. Financial ConglomeratesFinance Provides financial services | Finance |
Pasithea Therapeutics Corp.
 Pasithea Therapeutics Corp. Pharmaceuticals: MajorHealth Technology Engages in research and development of drugs for mental health disorders | Health Technology |
Dunraven Capital Partners Ltd.
Dunraven Capital Partners Ltd. MiscellaneousMiscellaneous Functions as an investment holding and financing company | Miscellaneous |
Lehman Brother Holding, Inc. |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
